Dr. Jula Veerapong, peritoneal mesothelioma specialist

Dr. Jula Veerapong

Associate Professor, UC San Diego

Surgical oncologist Dr. Jula Veerapong specializes in treating surface malignancies such as peritoneal mesothelioma at the University of California San Diego School of Medicine.

Get in touch

About Jula Veerapong

Accolades
  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Research Excellence icon

    Excellence in Research

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

  • Board Certified icon

    Board Certified in Medical Oncology

Veerapong performs cytoreductive surgery with heated intraperitoneal chemotherapy (HIPEC), a combination that has worked well for patients with mesothelioma cancer.

In 2017, he joined the staff at Moores Cancer Center, which has been using the HIPEC procedure for more than a decade.

Veerapong previous served for six years at the St. Louis University School of Medicine, where he started and developed a HIPEC program as director of the Surface Malignancies Program.

He was first trained in the procedure during his fellowship at the University of Texas MD Anderson Cancer Center.

HIPEC typically follows a complete cytoreduction of tumor cells in the abdominal cavity. It involves circulating a heated chemotherapy solution through the abdomen for 90 minutes and is designed to kill any microscopic tumor cells that evaded the surgeon.

Unlike systemic chemotherapy, HIPEC delivers the drug directly to the affected area and decreases the toxicity on other parts of the body.

The procedure has changed the way a diagnosis of peritoneal mesothelioma is perceived, often more than doubling the expected survival time of patients. It also has been used successfully with colorectal and appendix cancers at the UC San Diego School of Medicine.

Veerapong leads an Enhanced Recovery After Surgery Program for patients who have undergone HIPEC. The program is designed to enhance and streamline care and recovery by establishing protocols for patients and staff during the pre-admission, pre-operative, inter-operative and post-operative stages.

Contributing to the Cancer Treatment Field

Veerapong specializes in a variety of gastrointestinal malignancies. He treats those with appendiceal cancer, colorectal cancer, gynecologic malignancies and pseudomyxoma peritonei.

His research has included minimally-invasive techniques and the utilization of HIPEC for ovarian cancer. As an associate professor, he also works with the residency and fellowship programs at UC San Diego.

Veerapong earned his degree from the University of Illinois Urbana-Champaign College of Medicine. He completed his residency in general surgery at the University of Chicago Medical Center.

He speaks regularly at national and international medical conventions, and his work has been published in Clinical Cancer Research, Cancer Research and the Journal of Gastrointestinal Surgery.

He is a member of the Society of Surgical Oncology and the Association for Academic Surgery. In St. Louis, he was honored with the Vallee Willman Award for Excellence in Surgical Education for his work with residents.

Disclaimer: Dr. Jula Veerapong has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get the Best Treatment Options

Find a Doctor
Asbestos.com Mesothelioma Packet

Order Your Free Treatment Guide

Get Yours Now

Find a Mesothelioma Clinical Trial Near You

Get Help Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Daniel King, Content Writer for Asbestos.com
Edited by

2 Cited Article Sources

  1. UC San Diego Health. (n.d.). Jula Veerapong, MD.
    Retrieved from: https://providers.ucsd.edu/details/32784/jula-veerapong-cancer-surgery-la_jolla
  2. UC San Diego School of Medicine. (2017, November 16). Press Release. Team HIPEC: Expanding Use of Heated Intraperitoneal Chemoperfusion. Retrieved from: https://medschool.ucsd.edu/som/surgery/news-events/Pages/Team-HIPEC---Expanding-Use-of-Heated-Intraperitoneal-Chemoperfusion.aspx
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

On This Page

Back to Top

Share this article

Last Modified September 13, 2019

Get Your Free Mesothelioma Guide Chat live with a patient advocate now